Please login to the form below

Not currently logged in
Email:
Password:

RSV

This page shows the latest RSV news and features for those working in and with pharma, biotech and healthcare.

Janssen’s RSV vaccine provides high protection against respiratory infections

Janssen’s RSV vaccine provides high protection against respiratory infections

The phase 2b data showed the RSV vaccine provided 80% protection against lower respiratory infections in adults aged 65 and older. ... The positive efficacy results from the CYPRESS study reinforce the potential of this investigational RSV vaccine in

Latest news

More from news
Approximately 5 fully matching, plus 45 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Dutch biotech Mucosis promotes Thomas Johnston to CEO Dutch biotech Mucosis promotes Thomas Johnston to CEO

    development and commercialisation of the Mimopath platform including our RSV vaccine candidate.". ... During the last 12 months Mucosis has completed a clinical proof of concept study in human influenza for Mimopath and advanced respiratory syncytial

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...